Targeting the Androgen Signaling Axis in Prostate Cancer

被引:76
作者
Dai, Charles [1 ,2 ,3 ]
Dehm, Scott M. [4 ,5 ,6 ]
Sharifi, Nima [7 ,8 ,9 ,10 ,11 ,12 ]
机构
[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA
[5] Univ Minnesota, Dept Urol, Minneapolis, MN USA
[6] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[7] Cleveland Clin, Lerner Res Inst, Genitourinary Malignancies Res Ctr, Cleveland, OH USA
[8] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH USA
[9] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol, Cleveland, OH USA
[10] Univ Miami, Miller Sch Med, Desai Sethi Urol Inst, Miami, FL USA
[11] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL USA
[12] Univ Miami, Desai Sethi Urol Inst, Miller Sch Med, 1600 NW 10th Ave,6026 Rosenstiel Med Sci Bldg, Miami, FL 33136 USA
关键词
STEROID-BINDING CHARACTERISTICS; RECEPTOR GENE; DEPRIVATION THERAPY; TRANSCRIPTIONAL ACTIVATION; INCREASED SURVIVAL; CLINICAL-OUTCOMES; DNA-REPAIR; PHASE-II; IN-VITRO; CASTRATION;
D O I
10.1200/JCO.23.00433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of the androgen receptor (AR) and AR-driven transcriptional programs is central to the pathophysiology of prostate cancer. Despite successful translational efforts in targeting AR, therapeutic resistance often occurs as a result of molecular alterations in the androgen signaling axis. The efficacy of next-generation AR-directed therapies for castration-resistant prostate cancer has provided crucial clinical validation for the continued dependence on AR signaling and introduced a range of new treatment options for men with both castration-resistant and castration-sensitive disease. Despite this, however, metastatic prostate cancer largely remains an incurable disease, highlighting the need to better understand the diverse mechanisms by which tumors thwart AR-directed therapies, which may inform new therapeutic avenues. In this review, we revisit concepts in AR signaling and current understandings of AR signaling-dependent resistance mechanisms as well as the next frontier of AR targeting in prostate cancer.
引用
收藏
页码:4267 / +
页数:13
相关论文
共 165 条
[1]   The Molecular Taxonomy of Primary Prostate Cancer [J].
Abeshouse, Adam ;
Ahn, Jaeil ;
Akbani, Rehan ;
Ally, Adrian ;
Amin, Samirkumar ;
Andry, Christopher D. ;
Annala, Matti ;
Aprikian, Armen ;
Armenia, Joshua ;
Arora, Arshi ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Barbieri, Christopher E. ;
Bauer, Thomas ;
Benz, Christopher C. ;
Bergeron, Alain ;
Beroukhim, Rameen ;
Berrios, Mario ;
Bivol, Adrian ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
dos Reis, Rodolfo Borges ;
Boutros, Paul C. ;
Bowen, Jay ;
Bowlby, Reanne ;
Boyd, Jeffrey ;
Bradley, Robert K. ;
Breggia, Anne ;
Brimo, Fadi ;
Bristow, Christopher A. ;
Brooks, Denise ;
Broom, Bradley M. ;
Bryce, Alan H. ;
Bubley, Glenn ;
Burks, Eric ;
Butterfield, Yaron S. N. ;
Button, Michael ;
Canes, David ;
Carlotti, Carlos G. ;
Carlsen, Rebecca ;
Carmel, Michel ;
Carroll, Peter R. ;
Carter, Scott L. ;
Cartun, Richard ;
Carver, Brett S. ;
Chan, June M. ;
Chang, Matthew T. ;
Chen, Yu .
CELL, 2015, 163 (04) :1011-1025
[2]   Genomic correlates of clinical outcome in advanced prostate cancer [J].
Abida, Wassim ;
Cyrta, Joanna ;
Heller, Glenn ;
Prandi, Davide ;
Armenia, Joshua ;
Coleman, Ilsa ;
Cieslik, Marcin ;
Benelli, Matteo ;
Robinson, Dan ;
Van Allen, Eliezer M. ;
Sboner, Andrea ;
Fedrizzi, Tarcisio ;
Mosquera, Juan Miguel ;
Robinson, Brian D. ;
De Sarkar, Navonil ;
Kunju, Lakshmi P. ;
Tomlins, Scott ;
Wu, Yi Mi ;
Rodrigues, Daniel Nava ;
Loda, Massimo ;
Gopalan, Anuradha ;
Reuter, Victor E. ;
Pritchard, Colin C. ;
Mateo, Joaquin ;
Bianchini, Diletta ;
Miranda, Susana ;
Carreira, Suzanne ;
Rescigno, Pasquale ;
Filipenko, Julie ;
Vinson, Jacob ;
Montgomery, Robert B. ;
Beltran, Himisha ;
Heath, Elisabeth I. ;
Scher, Howard I. ;
Kantoff, Philip W. ;
Taplin, Mary-Ellen ;
Schultz, Nikolaus ;
deBono, Johann S. ;
Demichelis, Francesca ;
Nelson, Peter S. ;
Rubin, Mark A. ;
Chinnaiyan, Arul M. ;
Sawyers, Charles L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (23) :11428-11436
[3]   Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer [J].
Agarwal, Neeraj ;
Hahn, Andrew W. ;
Gill, David M. ;
Farnham, James M. ;
Poole, Austin I. ;
Cannon-Albright, Lisa .
JAMA ONCOLOGY, 2017, 3 (06) :856-857
[4]   Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition [J].
Annala, Matti ;
Taavitsainen, Sinja ;
Khalaf, Daniel J. ;
Vandekerkhove, Gillian ;
Beja, Kevin ;
Sipola, Joonatan ;
Warner, Evan W. ;
Herberts, Cameron ;
Wong, Amanda ;
Fu, Simon ;
Finch, Daygen L. ;
Oja, Conrad D. ;
Vergidis, Joanna ;
Zulfiqar, Muhammad ;
Eigl, Bernhard J. ;
Kollmansberger, Christian K. ;
Nykter, Matti ;
Gleave, Martin E. ;
Chi, Kim N. ;
Wyatt, Alexander W. .
CLINICAL CANCER RESEARCH, 2021, 27 (16) :4610-4623
[5]   Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Luber, Brandon ;
Wang, Hao ;
Chen, Yan ;
Zhu, Yezi ;
Silberstein, John L. ;
Taylor, Maritza N. ;
Maughan, Benjamin L. ;
Denmeade, Samuel R. ;
Pienta, Kenneth J. ;
Paller, Channing J. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2149-+
[6]   Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Luber, Brandon ;
Wang, Hao ;
Chen, Yan ;
Nakazawa, Mary ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
JAMA ONCOLOGY, 2015, 1 (05) :582-591
[7]   ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer [J].
Armstrong, Andrew J. ;
Szmulewitz, Russell Z. ;
Petrylak, Daniel P. ;
Holzbeierlein, Jeffrey ;
Villers, Arnauld ;
Azad, Arun ;
Alcaraz, Antonio ;
Alekseev, Boris ;
Iguchi, Taro ;
Shore, Neal D. ;
Rosbrook, Brad ;
Sugg, Jennifer ;
Baron, Benoit ;
Chen, Lucy ;
Stenzl, Arnulf .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) :2974-+
[8]   Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study [J].
Armstrong, Andrew J. ;
Halabi, Susan ;
Luo, Jun ;
Nanus, David M. ;
Giannakakou, Paraskevi ;
Szmulewitz, Russell Z. ;
Danila, Daniel C. ;
Healy, Patrick ;
Anand, Monika ;
Rothwell, Colin J. ;
Rasmussen, Julia ;
Thornburg, Blair ;
Berry, William R. ;
Wilder, Rhonda S. ;
Lu, Changxue ;
Chen, Yan ;
Silberstein, John L. ;
Kemeny, Gabor ;
Galletti, Giuseppe ;
Somarelli, Jason A. ;
Gupta, Santosh ;
Gregory, Simon G. ;
Scher, Howard I. ;
Dittamore, Ryan ;
Tagawa, Scott T. ;
Antonarakis, Emmanuel S. ;
George, Daniel J. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (13) :1120-+
[9]   Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade [J].
Arora, Vivek K. ;
Schenkein, Emily ;
Murali, Rajmohan ;
Subudhi, Sumit K. ;
Wongvipat, John ;
Balbas, Minna D. ;
Shah, Neel ;
Cai, Ling ;
Efstathiou, Eleni ;
Logothetis, Chris ;
Zheng, Deyou ;
Sawyers, Charles L. .
CELL, 2013, 155 (06) :1309-1322
[10]   Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer [J].
Azad, Arun A. ;
Volik, Stanislav V. ;
Wyatt, Alexander W. ;
Haegert, Anne ;
Le Bihan, Stephane ;
Bell, Robert H. ;
Anderson, Shawn A. ;
McConeghy, Brian ;
Shukin, Robert ;
Bazov, Jenny ;
Youngren, Jack ;
Paris, Pamela ;
Thomas, George ;
Small, Eric J. ;
Wang, Yuzhuo ;
Gleave, Martin E. ;
Collins, Colin C. ;
Chi, Kim N. .
CLINICAL CANCER RESEARCH, 2015, 21 (10) :2315-2324